|
시장보고서
상품코드
2058324
암세포 시장 : 암세포 유형별, 용도별, 최종 사용자별, 지역별Cancer Cell Market, By Cancer Cell Type, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
암세포 시장은 2026년에 128억 달러에 달하고 2033년까지 244억 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 10.3%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 128억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 10.30% | 시장 규모 예측(2033년) : | 244억 달러 |
세계 암세포 시장에는 폐암, 유방암 및 기타 암 치료에 사용되는 다양한 치료법이 포함됩니다. 암의 치료법으로는 화학요법, 방사선 요법, 면역요법, 호르몬 요법, 표적 치료 등이 있습니다. 암의 유형로는 암종, 육종, 백혈병 등이 있으며, 이들은 일상적인 생활 습관, 더 흔한 경우로는 담배와 같은 발암 물질에 의해 유발됩니다.
시장 역학
주요 기업들은 세계 암세포 시장에서 입지를 강화하기 위해 소세포폐암 등의 치료에 대한 연구 개발에 주력하고 있습니다. 예를 들어, 2019년 12월, 로슈는 미국 식품의약국(FDA)이 상피성장인자 수용체(EGFR) 변이 및 미분화 대세포 림프종 키나아제(ALK)의 유전적 종양 이상이 없는 전이성 비편평상피 비소세포폐암(NSCLC) 성인 환자를 대상으로 한 초기(1차 선택) 치료제로, 자사의 테센트릭(아테졸리주맙)과 화학요법(아브라크산)의 병용 요법을 승인했다고 발표했습니다.
본 조사의 주요 특징
- 본 보고서는 세계의 암세포 시장의 현황 및 미래 전망에 대해 전해드립니다. 암세포 시장은 암세포의 유형, 용도, 최종 사용자 및 지역을 기준으로 세분화되어 있습니다.
- 본 보고서는 세계의 암세포 시장에 대한 상세한 분석을 제공하며, 예측 기간(2026-2033년) 동안 시장 규모 및 연평균 성장률(CAGR, %)을 제시하고 있습니다.
- 본 보고서는 각 부문별 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다. 또한 시장 성장 촉진요인, 제약 요인, 기회, 국가별 전망 및 주요 기업들이 채택하고 있는 경쟁 전략에 대한 귀중한 인사이트를 제공합니다.
- 본 보고서에서는 다음의 주요 지표를 바탕으로 세계 암세포 시장의 주요 기업들을 분석했습니다. 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 주요 발전 사항 및 향후 계획.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 암세포 시장 보고서는 투자자, 제품 개발자 및 제조업체, 유통업체, 의료 기관, 연구 기관, 신규 진출기업, 금융 애널리스트 등 해당 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 세계의 암세포 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사 결정 과정에서 큰 도움을 얻을 수 있습니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 암세포 시장 : 암세포 유형별(2021-2033년)
제5장 세계의 암세포 시장 : 용도별(2021-2033년)
제6장 세계의 암세포 시장 : 최종 사용자별(2021-2033년)
제7장 세계의 암세포 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
KTH 26.06.19Cancer Cell Market is estimated to be valued at USD 12.8 Bn in 2026 and is expected to reach USD 24.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 12.8 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.30% | 2033 Value Projection: | USD 24.4 Bn |
The global cancer cell market include various therapies used for the treatment of various cancers such as lung cancer, breast cancer, and others. There are various therapies for treatment of cancer such as chemotherapy, radiation therapy, immunotherapy, hormone therapy, targeted drug therapy and others. The types of cancer such as carcinomas, sarcomas, leukemia, and others are caused due day to day lifestyles, and or more often, caused by carcinogens (cancer causing substances) such as tobacco etc.
Market Dynamics
Key players are focusing on research and development for treatment of cancers such as small cell lung cancer to strengthen their position in the global cancer cell market. For instance, in December 2019, Roche announced that the U.S. Food and Drug Administration (FDA) approved its Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane) for the initial (first-line) treatment of adults with metastatic non-squamous non-small cell lung cancer (NSCLC) with no epidermal growth factor receptor (EGFR) mutations and anaplastic large-cell lymphoma kinase (ALK) genomic tumor aberrations.
Key features of the study
- This report studies the current scenario as well as the future potential of the global cancer cell market. The market for cancer cell market is segmented on basis of cancer cell type, application, end user, and region.
- This report provides in-depth analysis of the global cancer cell market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2026-2033)
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
- It profiles leading players in the global cancer cell market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
- The global cancer cell market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
- Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global cancer cell market
Market Segmentation
- By Cancer Cell Type (Revenue, USD Bn, 2021-2033)
- Carcinomas
- Sarcomas
- Leukemia
- Others
- By Application (Revenue, USD Bn, 2021-2033)
- Chemotherapy
- Radiation Therapy
- Immunotherapy
- Hormone Therapy
- Targeted Drug Therapy
- Others
- By End User (Revenue, USD Bn, 2021-2033)
- Hospitals & Clinics
- Specialty Clinics
- Diagnostic Laboratories
- By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Abbott Laboratories
- Novartis International AG
- Arcellx
- Autolus Therapeutics
- Kite Pharma
- Cellectis
- Celyad Oncology
- Crescendo Biologics Limited
- GammaDelta Therapeutics Ltd.
- Bio-Rad Laboratories Inc
- QIAGEN Inc
- Thermo Fisher Scientific
- Merck Millipore
- Siemens Healthineers AG
- GE Healthcare
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Cancer Cell Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Key Developments
- New Product Launches/Approvals
- Merger-Acquisition Scenario
- Regulatory Scenario
- Pipeline Analysis
- Epidemiology
- PEST Analysis
- Reimbursement
4. Global Cancer Cell Market, By Cancer Cell Type, 2021-2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Carcinomas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sarcomas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Cancer Cell Market, By Application, 2021-2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Radiation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hormone Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Targeted Drug Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Cancer Cell Market, By End User, 2021-2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Cancer Cell Market, By Region, 2021-2033 (USD Bn)
- Introduction
- Market Share Analysis, By Country, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, For Countries, 2022-2033
- North America
- Introduction
- Market Size and Forecast, By Cancer Cell Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Cancer Cell Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Cancer Cell Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Cancer Cell Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Cancer Cell Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Cancer Cell Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Company Profiles
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis International AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Arcellx
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Autolus Therapeutics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Kite Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cellectis
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Celyad Oncology
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Crescendo Biologics Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GammaDelta Therapeutics Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bio-Rad Laboratories Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- QIAGEN Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Thermo Fisher Scientific
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck Millipore
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Siemens Healthineers AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GE Healthcare
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Abbott Laboratories
9. Section
- References
- Research Methodology
- About us and Sales Contact
